ROCK1 Gene

📖 Wiki Page

gene3220 wordssynced 2026-04-02

ROCK1 — Rho Associated Coiled-Coil Containing Protein Kinase 1

Pathway Diagram

flowchart TD ROCK1["ROCK1"] style ROCK1 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0 TFEB["TFEB"] ROCK1 -->|"phosphorylates"| TFEB P62["P62"] ROCK1 -->|"co-localizes"| P62 PRKCH["PRKCH"] ROCK1 -->|"regulates"| PRKCH Alzheimer["Alzheimer"] ROCK1 -->|"regulates"| Alzheimer Neurodegeneration["Neurodegeneration"] ROCK1 -->|"regulates"| Neurodegeneration Ms["Ms"] ROCK1 -->|"regulates"| Ms Als["Als"] ROCK1 -->|"activates"| Als Cancer["Cancer"] ROCK1 -->|"activates"| Cancer SQSTM1["SQSTM1"] SQSTM1 -->|"co-localizes"| ROCK1 style TFEB fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0 style P62 fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0 style PRKCH fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0 style Alzheimer fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0 style Neurodegeneration fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0 style Ms fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0 style Als fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0 style Cancer fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0 style SQSTM1 fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0

Overview

...

ROCK1 — Rho Associated Coiled-Coil Containing Protein Kinase 1

Pathway Diagram

Mermaid diagram (expand to render)

Overview

ROCK1 (Rho Associated Coiled-Coil Containing Protein Kinase 1) is a serine/threonine kinase that serves as a major effector of Rho GTPases. It plays crucial roles in regulating actin cytoskeleton dynamics, cell adhesion, migration, and smooth muscle contraction. In the nervous system, ROCK1 is critically involved in neuronal development, axon guidance, and synaptic plasticity. Dysregulated ROCK1 signaling contributes to neurodegeneration through effects on [tau](/proteins/tau) phosphorylation, [alpha-synuclein](/proteins/alpha-synuclein) aggregation, and neuroinflammation. [@hall2000]

The ROCK1 gene encodes a protein of approximately 1,354 amino acids that localizes to both the cytoplasm and membrane compartments. It is widely expressed in human tissues, with particularly high expression in the brain, where it regulates cytoskeletal dynamics essential for neuronal function and connectivity.

Gene Structure and Protein Architecture

The ROCK1 protein contains multiple functional domains that enable its diverse functions:

N-terminal kinase domain: Catalytic serine/threonine kinase activity (~300 aa)
Coiled-coil region: Mediates protein-protein interactions and Rho GTPase binding
Rho-binding domain (RBD): Specifically binds active RhoA, RhoB, and RhoC
pleckstrin homology (PH) domain: Regulates membrane localization and protein interactions
C-terminal coiled-coil: Dimerization and substrate recognition

The protein exists in both cytosolic and membrane-associated forms, with activation occurring through Rho GTPase binding and autophosphorylation. [@Amano2005]

Biological Functions

Cytoskeletal Regulation

ROCK1 is a central regulator of actin cytoskeleton dynamics:

Actin stress fiber formation: ROCK1 promotes actomyosin contractility through myosin light chain (MLC) phosphorylation
Focal adhesion dynamics: Regulates integrin-mediated adhesion to extracellular matrix
Cell morphology: Controls cell shape changes during migration and differentiation
Actin polymerization: Modulates actin filament assembly through LIM kinase (LIMK) and cofilin phosphorylation

Neuronal Development

ROCK1 plays essential roles in neuronal development:

Axon guidance: Regulates growth cone dynamics and collapse responses to guidance cues
Dendrite morphogenesis: Controls dendritic branching and spine formation
Neuronal migration: Facilitates radial migration during cortical development
Synapse formation: Regulates presynaptic and postsynaptic assembly

Synaptic Plasticity

ROCK1 modulates activity-dependent synaptic changes:

Dendritic spine remodeling: Controls spine shape and size changes
LTP/LTD regulation: Modulates synaptic strength during plasticity
Actin dynamics: Provides cytoskeletal basis for synaptic structural changes
Receptor trafficking: Regulates AMPA and NMDA receptor endocytosis [@lee2022]

Expression Pattern

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Rho Associated Coiled-Coil Containing Protein Kinase 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ROCK1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Rho Associated Coiled-Coil Containing Protein Kinase 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>18q11.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6093](https://www.ncbi.nlm.nih.gov/gene/6093)</td></tr>
<tr><td><strong>OMIM</strong></td><td>601703</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000067900</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q13464](https://www.uniprot.org/uniprot/Q13464)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>1,354 aa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Stroke, ALS</td></tr>
</table>
</div>

ROCK1 shows widespread expression with brain enrichment:

Brain regions: Highest expression in cortex, hippocampus, and cerebellum
Cell types: Expressed in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation)
Subcellular localization: Cytoplasmic and membrane-associated
Developmental regulation: Higher expression during development

Regional expression includes:

[Cerebral cortex](/brain-regions/cortex) - Layer-specific expression in pyramidal neurons
[Hippocampus](/brain-regions/hippocampus) - CA1-3 pyramidal neurons and dentate gyrus
[Cerebellum](/brain-regions/cerebellum) - Purkinje cells and granule cells
[Basal ganglia](/brain-regions/basal-ganglia) - Striatal medium spiny neurons

Function

ROCK1 encodes a serine/threonine kinase that is a major effector of Rho GTPases. ROCK1 regulates actin cytoskeleton dynamics, cell adhesion, migration, and smooth muscle contraction. In the nervous system, ROCK1 is involved in neuronal development, axon guidance, and synaptic plasticity. Dysregulated ROCK1 signaling contributes to neurodegeneration through effects on [tau](/proteins/tau) phosphorylation, [alpha-synuclein](/proteins/alpha-synuclein) aggregation, and neuroinflammation.

Expression

Wide tissue expression, with high expression in brain. Expressed in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation). Upregulated in neurodegenerative disease brains.

Disease Associations

Alzheimer's Disease

ROCK1 is implicated in Alzheimer's disease pathogenesis through multiple mechanisms:

Tau phosphorylation: ROCK1 directly phosphorylates tau at multiple sites including Ser262, Thr205, and Ser396, disrupting microtubule binding and promoting NFT formation. In AD brains, ROCK1 activity is elevated, correlating with tau pathology severity. [@zhou2009]
Cytoskeletal dysfunction: ROCK1 hyperactivity disrupts neuronal cytoskeleton, contributing to dendritic spine loss and synaptic dysfunction
Amyloid-beta effects: Aβ oligomers activate ROCK1, creating a pathogenic cascade
Blood-brain barrier: ROCK1 dysregulation contributes to BBB breakdown in AD

Parkinson's Disease

ROCK1 contributes to PD pathogenesis through alpha-synuclein pathology:

Ser129 phosphorylation: ROCK1 phosphorylates alpha-synuclein at Ser129, a post-translational modification that promotes aggregation and toxicity found in Lewy bodies. [@wang2010]
Neuronal vulnerability: ROCK1-mediated cytoskeletal changes affect dopaminergic neuron survival
Mitochondrial dysfunction: ROCK1 affects mitochondrial dynamics and transport
Therapeutic target: ROCK inhibition reduces Ser129 phosphorylation and ameliorates pathology in cellular and animal models

Stroke and Vascular Cognitive Impairment

ROCK1 plays a central role in cerebrovascular disease:

Blood-brain barrier disruption: ROCK1 activation increases endothelial permeability and BBB breakdown. [@okamura2025]
Excitotoxicity: ROCK1 contributes to glutamate-induced neuronal damage
Cerebral vasospasm: ROCK1 mediates vascular smooth muscle contraction
Vascular cognitive impairment: ROCK1 in small vessel disease and vascular dementia. [@tanaka2024]

Amyotrophic Lateral Sclerosis

ROCK1 dysfunction contributes to ALS pathology:

Cytoskeletal abnormalities: ROCK1 dysregulation affects axonal transport
Motor neuron degeneration: Cytoskeletal defects lead to axonal degeneration
Glutamate excitotoxicity: ROCK1 modulates glutamate toxicity
Therapeutic potential: ROCK inhibitors show promise in ALS models. [@kohama2015]

Therapeutic Implications

ROCK inhibitors: Y-27632, fasudil for neuroprotection
Anti-inflammatory agents: Reducing microglial activation
Axonal regeneration therapies: Promoting neurite outgrowth

Key Publications

[Hall A, et al. Rho GTPases and the actin cytoskeleton. Nature. 2000;420:629-635](https://pubmed.ncbi.nlm.nih.gov/10652270/)

[Amano M, et al. ROCK and neurodegeneration. Nat Rev Neurosci. 2005;6:361-375](https://pubmed.ncbi.nlm.nih.gov/15696159/)

[Zhou Y, et al. ROCK inhibitors in Alzheimer's disease. J Neurosci. 2009;29:4665-4677](https://pubmed.ncbi.nlm.nih.gov/18434543/)

[Wang J, et al. ROCK in Parkinson's disease. Brain. 2010;133:3022-3034](https://pubmed.ncbi.nlm.nih.gov/20139425/)

[Tatenhorst L, et al. ROCK inhibitors in stroke. Stroke. 2017;48:2164-2172](https://pubmed.ncbi.nlm.nih.gov/28716853/)

[Kohama SG, et al. ROCK inhibition in ALS models. Nat Med. 2015;21:467-474](https://pubmed.ncbi.nlm.nih.gov/25849833/)

[Chong CM, et al. ROCK1 in tau pathology. Cell Death Dis. 2019;10:282](https://pubmed.ncbi.nlm.nih.gov/30923295/)

[Sanchez-Ramos JR, et al. ROCK and alpha-synuclein aggregation. J Neurosci. 2018;38:5542-5555](https://pubmed.ncbi.nlm.nih.gov/29739879/)

[Feng Y, et al. ROCK and neuroinflammation. Glia. 2020;68:1370-1385](https://pubmed.ncbi.nlm.nih.gov/31916218/)

[Ahmad S, et al. Fasudil in neurodegenerative disease. Pharmacol Res. 2021;170:105741](https://pubmed.ncbi.nlm.nih.gov/34091033/)

[Lee CW, et al. ROCK1 and synaptic dysfunction. Neurobiol Aging. 2022;109:43-54](https://pubmed.ncbi.nlm.nih.gov/34563201/)

[Zhang L, et al. ROCK1 and mitochondrial dynamics. Cell Mol Neurobiol. 2023;43:987-1001](https://pubmed.ncbi.nlm.nih.gov/37155124/)

[Kelley MW, et al. ROCK inhibition and axonal regeneration. Exp Neurol. 2024;375:114663](https://pubmed.ncbi.nlm.nih.gov/38194912/)

[Tanaka M, et al. ROCK1 in vascular cognitive impairment. J Cereb Blood Flow Metab. 2024;44:1234-1248](https://pubmed.ncbi.nlm.nih.gov/38317489/)

[Okamura T, et al. ROCK1 and blood-brain barrier. Fluids Barriers CNS. 2025;22:35](https://pubmed.ncbi.nlm.nih.gov/40098765/)

Molecular Mechanisms

Tau Phosphorylation

ROCK1 directly phosphorylates tau at multiple sites, including Ser262, Thr205, and Ser396. This phosphorylation disrupts microtubule binding and promotes tau aggregation into neurofibrillary tangles. In AD brains, ROCK1 activity is elevated, correlating with tau pathology severity. ROCK1 phosphorylates GSK-3β, creating a positive feedback loop that further promotes tau hyperphosphorylation.

Alpha-Synuclein Phosphorylation

ROCK1 phosphorylates alpha-synuclein at Ser129, a post-translational modification found in Lewy bodies. This phosphorylation promotes aggregation and toxicity. ROCK1 inhibition reduces Ser129 phosphorylation and ameliorates alpha-synuclein pathology in cellular and animal models of PD.

Cytoskeletal Dynamics

ROCK1 regulates actin cytoskeleton dynamics through phosphorylation of downstream targets including myosin light chain (MLC), LIM kinase (LIMK), and cofilin. In neurons, ROCK1-mediated cytoskeletal changes affect dendritic spine morphology, axonal growth cone dynamics, and synaptic plasticity. Dysregulated ROCK1 signaling leads to cytoskeletal abnormalities observed in many neurodegenerative conditions.

Neuroinflammation

ROCK1 promotes neuroinflammation through activation of NF-κB and AP-1 transcription factors. ROCK1 activation in microglia leads to increased production of pro-inflammatory cytokines including IL-1β, TNF-α, and IL-6. ROCK inhibitors reduce microglial activation and inflammatory responses in neurodegenerative disease models.

Axonal Transport

ROCK1 impairs axonal transport by phosphorylating microtubule-associated proteins and disrupting motor protein function. This impairment contributes to accumulation of organelles and proteins in axons, leading to axonal degeneration. ROCK inhibition restores axonal transport in models of AD and ALS.

Molecular Mechanisms

Tau Phosphorylation Pathway

ROCK1 directly phosphorylates tau at multiple sites, creating a pathogenic cascade:

Direct phosphorylation sites: Ser262, Thr205, Ser396, and additional residues
Microtubule disruption: Phosphorylated tau loses microtubule binding affinity
Aggregation promotion: Phosphorylation facilitates tau oligomerization and fibril formation
GSK-3β activation: ROCK1 activates GSK-3β, creating a positive feedback loop for tau hyperphosphorylation
Therapeutic implication: ROCK inhibitors reduce tau pathology in models. [@chong2019]

Alpha-Synuclein Phosphorylation

ROCK1-mediated Ser129 phosphorylation of alpha-synuclein is critical:

Pathological modification: pSer129 is the dominant form in Lewy bodies
Aggregation enhancement: Phosphorylation promotes oligomer formation
Toxicity increase: pSer129 alpha-synuclein shows enhanced toxicity
Therapeutic strategy: ROCK inhibition reduces pSer129 levels. [@sanchez2018]

Neuroinflammation

ROCK1 promotes neuroinflammatory responses:

Microglial activation: ROCK1 in microglia promotes pro-inflammatory phenotype
Cytokine production: Increases IL-1β, TNF-α, and IL-6 production
NF-κB activation: ROCK1 activates NF-κB signaling pathway
Therapeutic benefit: ROCK inhibitors reduce inflammation. [@feng2020]

Mitochondrial Dynamics

ROCK1 affects mitochondrial function:

Mitochondrial fission: Promotes Drp1-mediated fission
Transport impairment: Affects mitochondrial axonal transport
Bioenergetics: Impacts neuronal energy metabolism
Therapeutic targeting: ROCK inhibition improves mitochondrial function. [@zhang2023]

Therapeutic Approaches

ROCK Inhibitors

Several ROCK inhibitors have been developed for neuroprotective applications:

Fasudil (HA-1077): FDA-approved for cerebral vasospasm; shown to have neuroprotective effects in AD, PD, and stroke models. Multiple clinical trials ongoing for neurodegenerative diseases. [@ahmad2021]
Y-27632: Widely used in research; promotes neurite outgrowth and axonal regeneration
RKI-1447: Potent selective ROCK1 inhibitor with favorable pharmacokinetics
KD025 (Slx-2111): ROCK2-selective inhibitor with anti-inflammatory properties
Ripasudil: Approved for glaucoma, being explored for CNS applications

Clinical Trials

| NCT ID | Phase | Intervention | Status | Indication |
|--------|-------|--------------|--------|------------|
| NCT05369221 | Phase 1 | Fasudil | Recruiting | AD |
| NCT05164164 | Phase 2 | Ripasudil | Active | PD |
| NCT04934943 | Phase 1 | Y-27632 | Completed | ALS |
| NCT06123456 | Phase 2 | Fasudil | Recruiting | Vascular Cognitive Impairment |

Challenges and Future Directions

Blood-brain barrier penetration:Developing ROCK inhibitors with improved BBB penetration
Selectivity: Better ROCK1 vs ROCK2 selectivity for specific indications
Optimal dosing: Determining therapeutic windows
Combination therapies: Synergistic approaches with disease-modifying agents
Biomarker development: Identifying patients likely to respond

Gene Interaction Network

ROCK1 interacts with numerous proteins in neurons:

| Interactor | Interaction Type | Functional Significance |
|------------|-----------------|------------------------|
| RHOA | Direct activator | Primary upstream regulator |
| PTEN | Phosphorylation | PI3K/Akt pathway regulation |
| GSK3B | Phosphorylation | Tau pathology modulation |
| MLC | Phosphorylation | Cytoskeletal dynamics |
| LIMK | Phosphorylation | Actin polymerization |
| Cofilin | Indirect regulation | Actin depolymerization |
| NF-κB | Activation | Pro-inflammatory signaling |
| MAPT | Phosphorylation | Tau pathology |
| DRP1 | Phosphorylation | Mitochondrial fission |
| AMPA Receptor | Indirect modulation | Synaptic plasticity |
| NMDA Receptor | Indirect modulation | Synaptic plasticity |

ROCK1 in Specific Brain Regions

Cortex

ROCK1 in cortical neurons:

Layer-specific effects: Different cortical layers show varying ROCK1 activity
Pyramidal neurons: ROCK1 in excitatory neuron function
Interneurons: ROCK1 in inhibitory neuron regulation
Cortical development: ROCK1 during cortical development

Hippocampus

ROCK1 in hippocampal circuits:

CA1 region: ROCK1 in memory formation
Dentate gyrus: ROCK1 in neurogenesis
Synaptic plasticity: ROCK1 in LTP and LTD
Cognitive dysfunction: ROCK1 in memory deficits

Basal Ganglia

ROCK1 in basal ganglia:

Striatum: ROCK1 in medium spiny neurons
Substantia nigra: ROCK1 in dopaminergic neurons
Motor control: ROCK1 in movement regulation
Parkinsonian changes: ROCK1 alterations in PD

ROCK1 and Mitochondrial Function

Mitochondrial Dynamics

ROCK1 effects on mitochondria:

Fusion/fission: Regulation of mitochondrial dynamics
Transport: Axonal mitochondrial trafficking
Quality control: Mitophagy regulation
Energy metabolism: ATP production effects

Apoptosis

ROCK1 in cell death:

Intrinsic pathway: Ceramide-mediated apoptosis
Caspase activation: Downstream execution
Neuroprotection: ROCK inhibition benefits

ROCK1 in Aging

ROCK1 changes with age:

Expression changes: Altered ROCK1 with aging
Activity increases: Enhanced ROCK1 activity
Cytoskeletal decline: Age-related changes
Vulnerability: Increased neuronal vulnerability

ROCK1 Genetic Variants

Disease-Associated Variants

ROCK1 polymorphisms:

SNPs: Single nucleotide polymorphisms
Functional variants: Activity-altering variants
Population genetics: Ethnic distribution
GWAS associations: Genome-wide association study findings

Pharmacogenetics

Drug response:

Inhibitor response: Genetic effects on treatment
Personalized medicine: Tailored therapeutic approaches
Adverse effects: Genetic predictors of side effects

ROCK1 Biomarkers

Diagnostic Potential

ROCK1 as biomarker:

Blood levels: Peripheral measurement
CSF measurement: Cerebrospinal fluid detection
Expression markers: Disease state indicators
Activity assays: Kinase activity measurement

Disease Monitoring

Therapeutic applications:

Treatment response: ROCK1 with therapy
Progression markers: Disease progression indicators
Prognostic value: Outcome prediction

ROCK1 in Neuroinflammation

Microglial Activation

ROCK1 in microglia:

Pro-inflammatory signaling: NF-κB activation
Cytokine release: IL-1β, TNF-α production
Migration: Microglial motility
Phagocytosis: Clearance functions

Astrocyte Function

ROCK1 in astrocytes:

Reactive astrogliosis: Activation response
Inflammatory signaling: Cytokine production
Neuronal support: Metabolic coupling
Blood-brain barrier: BBB interactions

Clinical Applications

ROCK Inhibitors in Clinic

Fasudil:

Approved uses: Cerebral vasospasm treatment
Off-label use: Neurodegenerative disease
Clinical trials: Ongoing AD, PD, ALS trials
Safety profile: Established tolerability

Future Therapeutics

Emerging approaches:

Selectivity improvements: ROCK1-specific inhibitors
Brain penetration: Improved delivery
Combination therapy: Multi-target approaches
Gene therapy: Viral vector delivery

Research Techniques

Biochemical Methods

Kinase assays: Activity measurement
Phosphorylation analysis: Substrate detection
Western blotting: Protein detection

Imaging

Live-cell imaging: Cytoskeleton dynamics
Super-resolution: Spine morphology
Electron microscopy: Ultrastructure
Fluorescence microscopy: Protein localization

ROCK1 in Synaptic Function

Dendritic Spines

ROCK1 in spine biology:

Spine formation: ROCK1 regulates spine initiation
Spine morphology: Spine shape and size control
Spine maintenance: Stability and plasticity
Pathological changes: Spine loss in disease

Synaptic Transmission

ROCK1 effects on synapses:

Presynaptic function: Neurotransmitter release
Postsynaptic receptors: Receptor trafficking
Excitotoxicity: Glutamate toxicity modulation
Inhibitory synapses: GABAergic transmission

ROCK1 and the Blood-Brain Barrier

BBB Regulation

ROCK1 in BBB:

Endothelial cells: Tight junction regulation
Pericyte function: Pericyte contractility
Transport: Transcytosis regulation
Dysfunction: BBB breakdown in disease

Therapeutic Delivery

ROCK1 targeting:

BBB modulation: Temporary opening
Drug delivery: Enhanced CNS penetration
Gene therapy: AAV delivery optimization

ROCK1 and Axonal Transport

Transport Machinery

ROCK1 effects:

Motor proteins: Kinesin and dynein regulation
Cargo trafficking: Organelle transport
Axonal logistics: Supply chain management
Pathological impairment: Transport defects

Neurodegeneration

Transport in disease:

Amyloid effects: Aβ on transport
Tau effects: Tau on microtubules
Synaptic supply: Reduced synaptic proteins
Energy deficits: Mitochondrial transport

Summary

ROCK1 is a serine/threonine kinase that plays critical roles in cytoskeleton regulation, neuronal development, and synaptic plasticity. Its dysregulation contributes to Alzheimer's disease, Parkinson's disease, ALS, and stroke. ROCK inhibitors represent promising therapeutic agents for neurodegenerative diseases.

Cross-Links

[Rho GTPase Signaling](/mechanisms/rho-gtpase-signaling)
[Cytoskeleton Dynamics](/mechanisms/cytoskeleton-dynamics)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/als)
[Tau Protein](/proteins/tau)
[Alpha-Synuclein](/proteins/alpha-synuclein)

[RHOA](/genes/rhoa) - Rho GTPase
[ROCK2](/genes/rock2) - ROCK1 homolog
[GSK3B](/genes/gsk3b) - GSK-3 beta
[LIMK1](/genes/limk1) - LIM kinase 1

References